Serum neurofilament light chain reference database for individual application in paediatric care: a retrospective modelling and validation study

医学 背景(考古学) 儿科 队列 人口 百分位 多发性硬化 环境卫生 病理 免疫学 数学 生物 统计 古生物学
作者
Ahmed Abdelhak,Franziska Petermeier,Pascal Benkert,Sabine Schädelin,Johanna Oechtering,Aleksandra Maleska Maceski,Michael Kabesch,Tobias Geis,Otto Laub,Georg Leipold,Claudio Gobbi,Chiara Zecca,Ari Green,Hayrettin Tumani,Eline A.J. Willemse,Heinz Wiendl,Cristina Granziera,Ludwig Kappos,David Leppert,Emmanuelle L. Waubant
出处
期刊:Lancet Neurology [Elsevier BV]
卷期号:22 (9): 826-833 被引量:66
标识
DOI:10.1016/s1474-4422(23)00210-7
摘要

Background Neurological conditions represent an important driver of paediatric disability burden worldwide. Measurement of serum neurofilament light chain (sNfL) concentrations, a specific marker of neuroaxonal injury, has the potential to contribute to the management of children with such conditions. In this context, the European Medicines Agency recently declared age-adjusted reference values for sNfL a top research priority. We aimed to establish an age-adjusted sNfL reference range database in a population of healthy children and adolescents, and to validate this database in paediatric patients with neurological conditions to affirm its clinical applicability. Methods To generate a paediatric sNfL reference dataset, sNfL values were measured in a population of healthy children and adolescents (aged 0–22 years) from two large cohorts in Europe (the Coronavirus Antibodies in Kids from Bavaria study, Germany) and North America (a US Network of Paediatric Multiple Sclerosis Centers paediatric case-control cohort). Children with active or previous COVID-19 infection or SARS-CoV-2 antibody positivity at the time of sampling, or a history of primary systemic or neurological conditions were excluded. Linear models were used to restrospectively study the effect of age and weight on sNfL concentrations. We modelled the distribution of sNfL concentrations as a function of age-related physiological changes to derive reference percentile and Z score values via a generalised additive model for location, scale, and shape. The clinical utility of the new reference dataset was assessed in children and adolescents (aged 1–19 years) with neurological diseases (epilepsy, traumatic brain injury, bacterial CNS infections, paediatric-onset multiple sclerosis, and myelin oligodendrocyte glycoprotein antibody-associated disease) from the paediatric neuroimmunology clinic at the University of California San Francisco (San Francisco, CA, USA) and the Children's Hospital of the University of Regensburg (Regensburg, Germany). Findings Samples from 2667 healthy children and adolescents (1336 [50·1%] girls and 1331 [49·9%] boys; median age 8·0 years [IQR 4·0–12·0]) were used to generate the reference database covering neonatal age to adolescence (target age range 0–20 years). In the healthy population, sNfL concentrations decreased with age by an estimated 6·8% per year until age 10·3 years (estimated multiplicative effect per 1 year increase 0·93 [95% CI 0·93–0·94], p<0·0001) and was mostly stable thereafter up to age 22 years (1·00 [0·52–1·94], p>0·99). Independent of age, the magnitude of the effect of weight on sNfL concentrations was marginal. Samples from 220 children with neurological conditions (134 [60·9%] girls and 86 [39·1%] boys; median age 14·7 years [IQR 10·8–16·5]) were used to validate the clinical utility of the reference Z scores. In this population, age-adjusted sNfL Z scores were higher than in the reference population of healthy children and adolescents (p<0·0001) with higher effect size metrics (Cohen's d=1·56) compared with the application of raw sNfL concentrations (d=1·28). Interpretation The established normative sNfL values in children and adolescents provide a foundation for the clinical application of sNfL in the paediatric population. Compared with absolute sNfL values, the use of sNfL Z score was associated with higher effect size metrics and allowed for more accurate estimation of the extent of ongoing neuroaxonal damage in individual patients. Funding Swiss National Science Foundation, US National Institutes of Health, and the National Multiple Sclerosis Society.

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
李健的小迷弟的应助被早早采纳,获得10
刚刚
kk发布了新的文献求助30
刚刚
刚刚
张亚慧完成签到,获得积分10
1秒前
陶珊完成签到,获得积分10
1秒前
1秒前
Rea完成签到,获得积分10
2秒前
2秒前
mis姜发布了新的文献求助10
3秒前
3秒前
myuniv发布了新的文献求助10
3秒前
4秒前
忧郁致远完成签到,获得积分10
5秒前
6秒前
stc完成签到,获得积分10
6秒前
晨晨的应助被136726采纳,获得30
6秒前
6秒前
cfs完成签到,获得积分10
6秒前
重要冰蝶发布了新的文献求助30
8秒前
Sophia发布了新的文献求助10
8秒前
并玖发布了新的文献求助20
8秒前
无限飞风完成签到,获得积分10
9秒前
9秒前
秦千默发布了新的文献求助10
9秒前
9秒前
芒草lx发布了新的文献求助10
9秒前
9秒前
Hello的应助被cfs采纳,获得30
10秒前
10秒前
nn完成签到,获得积分10
11秒前
香蕉觅云的应助被DYY采纳,获得10
11秒前
jackson_WANG发布了新的文献求助20
11秒前
mor完成签到 ,获得积分10
12秒前
long完成签到 ,获得积分10
12秒前
12秒前
慕青的应助被王硕采纳,获得10
12秒前
风吹阔叶完成签到 ,获得积分10
12秒前
bobojiayou完成签到,获得积分10
13秒前
molihuakai的应助被科研通管家采纳,获得10
13秒前
和谐的雪巧完成签到,获得积分10
13秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
拉伸高分子熔体中缠结行为的模拟和小角中子散射研究 2000
Handbook of Sport Coaching Research 1000
Orthognathic Surgery - 2 Volume Set 500
高分子基功能界面水蒸发材料与应用研究 500
外场增强的水汽发电研究 500
基于结构调控的功能化水诱导发电材料与器件研究 500
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 计算机科学 工程类 有机化学 化学工程 生物化学 物理 复合材料 内科学 催化作用 光电子学 人工智能 细胞生物学 无机化学 物理化学 数学
热门帖子
关注 科研通微信公众号,转发送积分 8192903
求助须知:如何正确求助?哪些是违规求助? 9579346
关于积分的说明 21864636
捐赠科研通 7792529
什么是DOI,文献DOI怎么找? 3437107
关于科研通互助平台的介绍 2560653
邀请新用户注册赠送积分活动 2483937